Peter P. Pramstaller
Peter P. Pramstaller
Head of Institute
Institute for Biomedicine
Peter P. Pramstaller is the founding director and head of the Institute for Biomedicine. As clinical neurologist, biomedical researcher and manager, he had the opportunity and privilege over the last 20 years to oversee and coordinate large, multilevel cross-disciplinary research projects, and to network with the international clinical-scientific community and industry.
Peter studied Medicine at the University of Innsbruck and pursued his postgraduate training and specialization in Neurology at the University of Verona, Heidelberg and the National Hospital of Neurology and Neurosurgery, Queen Square, London. In 2003 he joined the medical faculty at the University of Luebeck (Germany), where he is currently Associate Professor.
Peter's primary research focus is the molecular genetics of movement disorders, with a special focus on common age-related neurodegenerative disorders such as Parkinson's disease (PD). After his return from the National Hospital of Neurology and Neurosurgery, Queen Square (1993-1995) he started a large scale neuroepidemiology project on PD and related disorders (NEPT-Study) in South Tyrol (Northern Italy), applying a combination of epidemiology and pedigree-based genetics. Strengthened by the success of these familial studies, in 2002 he started the “GenNova Health Care Program,” an extensive, two-stage survey aimed at characterizing the genetic epidemiology of Mendelian and complex diseases in South Tyrolean population isolates (MICROS-Study). In 2004 GenNova became the Institute of Genetic Medicine, focusing its studies on genetic-epidemiological analyses among the South Tyrolean population isolates. In 2009 the institute grew into today’s Institute for Biomedicine, which in 2011 launched the CHRIS-Study (Cooperative Health Research In South Tyrol), a large prospective population cohort study, focused on understanding how the interaction between factors such as genomic, metabolomic and environmental variation contributes to human health and disease.
Peter strongly believes in transdisciplinarity, convergence and synergy. Thus, beside his biomedical research and clinical-translational focus, he has a strong interest in the development and application of novel leadership and management models in science and healthcare.
Rettet die Medizin: Wie Ärzte das Ruder wieder selbst in die Hand nehmen können. Mit einem Geleitwort von Fredmund Malik
Rescue the Doctor: What Doctors Urgently Need to Know About the New World of Health Care
Partnership to Accelerate Covid-19 rEsearch in South TyrolDuration: January 2021 - June 2022Funding:
CHRIS-2D: a Dynamic Data infrastructure for biomedical research and innovation in South TyrolDuration: June 2020 - December 2022Funding:
MAGAZINE Science Stories that Inspire
"Shifting focus from disease to human health"
Synergy between Eurac Research and Human Technopole of Milan gives new life to health research in Italy
Covid-19: links between genes and disease severity
Bolzano research centre among institutions involved in a study to reveal human genome locations associated with Covid-19 severity